News Archive
Jessica Miller, PhD, awarded Susan G. Komen grant to study breast cancer-related chronic pain
This grant brings Komen’s total research investment in Arizona to more than $4.1 million since 1982. Dr. Miller is one of more than 50 early-career breast cancer researchers to receive a Komen award this year.
Partnership for Native American Cancer Prevention awarded $13 million
A unique collaboration between the UA Cancer Center and NAU to bring cancer prevention and biomedical research training to Native American communities in Arizona has received $13 million in additional funding.
UACC among founding members of the Academic Breast Cancer Consortium
The consortium of cancer organizations will allow more patients access to pharmaceutical clinical trials.
Partnership for Native American Cancer Prevention awarded $13 million
The Partnership for Native American Cancer Prevention has been awarded $13 million from the National Cancer Institute to continue bringing prevention and biomedical research training to Native American communities in Arizona. The partnership focuses on the Hopi Tribe, Tohono O’odham Nation and Navajo Nation of Arizona.
The Skin Cancer Institute at the University of Arizona Cancer Center presents the fifth annual Melanoma Walk Nov. 1
The goal for this year’s Melanoma Walk is to raise $60,000 to fight melanoma – a $5,000 increase from last year’s fundraising efforts.
Sydney E. Salmon, MD, named 'Oncology Luminary'
University of Arizona Cancer Center founding Director Sydney E. Salmon, MD, has been named an “Oncology Luminary” by the American Society of Clinical Oncology in celebration of its 50th anniversary.
Research study tests weight loss program for female colorectal cancer survivors
S1008 is a clinical trial to test whether an exercise and diet weight loss program can help overweight female colon or rectal cancer survivors reach a healthy body weight.
Healthbreak: UAMC's prostate cancer program offers patients a multi-faceted approach to care
Mitchell Sokoloff, MD, FACS discusses UAMC's Prostate Cancer Program, a well-established program using a multi-faceted approach to caring for patients, including clinical and research activities dating back to the 1980s.
Breakthroughs: Translational Research
While Thomas Grogan, MD, was in the process of redefining tissue analysis, he teamed up with a clinical oncologist in Thomas Miller, MD, to see how they could effectively turn their lymphoma-based research into life-saving therapies.
Breakthroughs: Personalized Cancer Care
Early in the 21st century, the National Cancer Institute hoped to establish personalized, individually tailored treatment as the standard of care for all cancer patients. With the human genome successfully sequenced in 2003, researchers were given the key that would go toward identifying an individual’s susceptibility for specific forms of cancer, along with the treatment options that would give each patient the best chance of success.
